Registro:

Referencias:

• Hengartner, M.O., The biochemistry of apoptosis (2000) Nature, 407, pp. 770-776
• Reed, J.C., Bcl-2 family proteins (1998) Oncogene, 17, pp. 3225-3236
• Gottlieb, R.A., Mitochondria and apoptosis (2001) Biol Signals Recept, 10, pp. 147-161
• Reed, J.C., Mechanism of apoptosis (2000) Am J Pathol, 157, pp. 1415-1430
• Korsmeyer, S.J., Wei, M.C., Saito, M., Weiter, K.J.O., Sclessinger, P.H., Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c (2000) Cell Death Differ, 7, pp. 1166-1173
• Adams, J.M., Cory, S., The Bcl-2 protein family: Arbiters of cell survival (1998) Science, 281, pp. 1322-1326
• Puthalakath, H., Huang, D.C., O'Reilly, L.A., Kung, S.M., Strasser, A., The proapoptotic activity of Bcl-2 family member Bim is regulated by interaction with the dyneim motor complex (1999) Mol Cell, 3, pp. 287-296
• Gross, A., Mc Donnell, J.M., Korsmeyer, S.J., Bcl-2 family members and the mitochondria in apoptosis (1999) Genes Dev, 13, pp. 1899-1911
• Yin, X.M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Bid-defficient mice resistant to Fas-induced hepatocellular apoptosis (1999) Nature, 400, pp. 886-891
• Reed, J.C., Tomaselli, K.J., Drug discovery opportunities from apoptosis research (2000) Curr Opin Biotechnol, 11, pp. 586-592
• Jackson, A.C., Apoptotic cell death in experimental rabies in suckling mice (1997) Acta Neuropathol, 95, pp. 159-164
• Allsopp, T.E., Scallan, M.F., Willims, A., Fazakerley, J.K., Virus infection induces neuronal apoptosis. A comparison with trophic factor withdrawal (1998) Cell Death Differ, 5, pp. 50-59
• Marianneau, P., Despres, P., Deubel, V., Recent knowledge on the pathogenesis of yellow fever and questions for the future (1999) Bull Soc Pathol Exot, 92, pp. 432-434
• Oberhaus, S.M., Dermody, T.S., Tyler, K.L., Apoptosis and the cytopathic effects of reovirus (1998) Curr Top Microbiol Immunol, 233, pp. 23-29
• Thornberry, N.A., Lazebnik, Y., Caspases: Enemies within (1998) Science, 281, pp. 1312-1316
• Duarte Dos Santos, C.N., Frenkiel, M.P., Courageot, M.P., Rocha, C.F., Vazielle-Falcoz, M.C., Wien, M.W., Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type-1 virus (2000) Virology, 274, pp. 292-308
• Thomson, B.J., Viruses and apoptosis (2001) Int J Exp Pathol, 82, pp. 65-76
• Nicholson, D.W., From bench to clinic with apoptosis-based therapeutic agents (2000) Nature, 407, pp. 810-816
• Saikumar, P., Dong, Z., Mikhailov, V., Denton, M., Weinberg, J.M., Venkatachalam, M.A., Apoptosis: Definition, Mechanisms and relevance to disease (1999) American J Med, 107, pp. 489-506
• Schlagbauer-Wadl, H., Klosner, G., Heere-Ress, E., Waltering, S., Moll, I., Wolff, K., Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SClD mice (2000) J Invest Dermatol, 114, pp. 725-730
• Jansen, B., Schlagbauer-Wadl, H., Brown, B.D., Bryan, R.N., Van Elsas, A., Muller, M., Bcl-2 antisense therapy chemosensetizes human melanoma in SCID mice (1998) Nature Med, 4, pp. 232-234
• Olie, R.A., Hafner, C., Kuttel, R., Sigrist, B., Willers, J., Dummer, R., Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages (2002) J Invest Dermatol, 118, pp. 505-512
• Waters, J.S., Webb, A., Cunningham, D., Clarke, P.A., Raynaud, F., Di Stefano, F., Phase I clinical and pharmacokinetic study of Bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma (2000) J Clin Oncol, 18, pp. 1812-1823
• Zangemeister-Wittke, U., Leech, S.H., Olie, R.A., Simoes-Wust, A.P., Gautschi, O., Luedke, G.H., A nobel bispecific antisense oligonucleotide inhibiting both Bcl-2 and Bcl-xL expression efficiently induces apoptosis in tumor cells (2000) Clin Cancer Res, 6, pp. 2547-2555
• Que, F.G., Phan, V.A., Phan, V.H., Celli, A., Batts, K., Larusso, N.F., Cholangiocarcinomas express Fas ligand and disable the Fas receptor (1999) Hepatology, 30, pp. 1398-1404
• Ashkenazi, A., Pai, R.C., Fong, S., Leung, S., Lawrence, D.A., Marsters, S.A., Safety and antitumor activity of recombinant soluble Apo2 ligand (1999) J Clin Invest, 104, pp. 155-162
• Griffith, T.S., Lynch, D.H., TRAIL a molecule with multiple receptors and control mechanisms (1998) Curr Opin Immunol, 10, pp. 559-563
• Marsters, S.A., Pitti, R.A., Sheridan, J.P., Ashkenazi, A., Control of apoptosis signaling by Apo2 ligand (1999) Recent Prog Horm Res, 54, pp. 225-234
• Walczak, H., Miller, R.E., Ariail, K., Gliniak, B., Griffith, T.S., Kubin, M., Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo (1999) Nature Med, 5, pp. 157-163
• Garcia-Calvo, M., Peterson, E.P., Leiting, B., Ruel, R., Nicholson, D.W., Thornberry, N.A., Inhibition of human caspases by peptide-based and macromolecular inhibitors (1998) J Biol Chem, 273, pp. 32608-32613
• Cursio, R., Gugenheim, J., Ricci, J.E., Crenesse, D., Rostagno, P., Maulon, L., A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis (1999) FASEB J, 13, pp. 253-261
• Daemen, M.A., Van 'T Veer, C., Denecker, G., Heemskerk, V.H., Wolfs, T.G., Clauss, M., Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation (1999) J Clin Invest, 104, pp. 541-549
• Endres, M., Namura, S., Shimizu-Sasamata, M., Waeber, C., Zhang, L., Gomez-Isla, T., Attenuation of delayed neuronal death mild focal ischemia in mice by inhibition of the caspase family (1998) J Cereb Blood Flow Metab, 18, pp. 238-247
• Farber, A., Connors, J.P., Friedlander, R.M., Wagner, R.J., Powell, R.J., Cronenwett, J.L., A specific inhibitor of apoptosis decreases tissue injury after intestinal ischemia-reperfusion in mice (1999) J Vasc Surg, 30, pp. 752-760
• Mocanu, M.M., Baxter, G.F., Yellon, D.M., Caspase inhibition and limitation of myocardial infarct size: Protection against lethal reperfusion injury (2000) Br J Pharmacol, 130, pp. 197-200
• Komdratyeva, A., Gale, K., Intracerebral injection of caspase-3 inhibitor prevents neuronal apoptosis after kainic acid-evoked status epilepticus (2000) Mol Brain Res, 75, pp. 216-224
• Li, M., Ona, V.O., Guegan, C., Chert, M., Jackson-Lewis, V., Andrews, Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model (2000) Science, 288, pp. 335-339
• Schierle, G.S., Hansson, O., Leist, M., Nicotera, P., Widner, H., Brundin, P., Caspase inhibition reduces apoptosis and increases survival of nigral transplants (1999) Nature Med, 5, pp. 97-100
• Movsesyan, V.A., Yakovlev, A.G., Fan, L., Faden, A.I., Effect of serine protease inhibitor on posttraumatic brain injury and neuronal apoptosis (2001) Exp Neurol, 167, pp. 366-375
• Vocero-Akbani, A.M., Heyden, N.V., Lissy, N.A., Ratner, L., Dowdy, S.F., Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein (1999) Nature Med, 5, pp. 29-33
• Dix, B.R., Edwards, S.J., Braithwaite, A.W., Does the antitumor adenovirus ONYX-O15/dl1520 selectively target cells defective in the p53 pathway? (2001) J Virol, 75, pp. 5443-5447

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------